1 terminated, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow peripheral blood stem cell transplantation (PBSC): new trials by email Literature Review of peripheral blood stem cell transplantation (PBSC) trials Research Report on peripheral blood stem cell transplantation (PBSC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer cyclosporine, mycophenolate mofetil, pentostatin - Chronic Myeloproliferative Disorders, Leukemia | Phase 1 / Phase 2 | Withdrawn | University of Nebraska | 2008-09-01 | 2023-08-14 | |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors amifostine trihydrate, busulfan, filgrastim - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 | Terminated | Masonic Cancer Center, University of Minnesota | 13 | 1998-11-01 | 2017-11-29 |
Anemia, Aplastic (1) · Astrocytoma (1) · Blast Crisis (1) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Chordoma (1) · Congenital Abnormalities (1) · Desmoplastic Small Round Cell Tumor (1) · Ependymoma (1) · Glioma (1) · Hepatoblastoma (1) · Kidney Neoplasms (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Accelerated Phase (1)
Masonic Cancer Center, University of Minnesota (1) · University of Nebraska (1)
United States (1)
John P. Perentesis, MD (1) · Robert Bociek, MD (1)
P30CA036727 (1)